Precocious puberty is a rare condition characterized by the development of secondary sexual characteristics before the median age for the sex. We report a 5 year and 7 month old girl who presented to us with precocious puberty who had a large anterior pituitary for the age.
Introduction
Precocious puberty in girls is defined as the development of secondary sexual characteristics before the age of eight years. There are two types, gonadotrophin dependent, or gonadotrophin independent. Gonadotrophin dependent precocious puberty is due to the premature activation of the hypothalamo-pituitary-ovarian axis, also known as central precocious puberty (CPP) (1) . CPP in girls is idiopathic in the majority of cases (2) .
Magnetic resonance imaging (MRI) of the head with special attention to the hypothalamo pituitary region is indicated in patients with CPP to look for a tumor or an intracerebral lesion after hormonal studies indicate a diagnosis of central precocious puberty (3, 4) . The size and shape of the normal pituitary gland vary considerably which is also affected by age, sex, and hormonal environment (5, 6, 7) . The increase in pituitary height and volume during puberty is well known (8, 9) . This increase during puberty is related to the changes in the endocrine hormone secretion during puberty specially due to the hyper-secretion of luteinizing hormone (LH) during this period (10, 11) . These morphological changes can mimic pituitary adenomas causing confusion in the diagnostic process. Therefore careful evaluation by a multidisciplinary team and correct interpretation of the imaging is important in the management of CPP before appropriate treatment is instituted.
We describe a child with central precocious puberty whose MRI of the brain was suggestive of an anterior
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Case presentation
A 5 year and 7 month old baby girl was referred to our pediatric endocrinology unit for evaluation of bilateral breast enlargement and growth of pubic hair of six months duration followed by one episode of vaginal spotting, initially noticed one week prior to her presentation. Her birth history was unremarkable and her growth and development were normal until 3 years of age. From 3 years of age her parents noticed she was growing taller than her elder sibling who was 1 year and 5 months older than her. She was noticed to be crossing her centiles in both height and weight at well baby clinics ( Figure 1 ). There was no history of early morning headache, vomiting, visual disturbances, fits or past history of cranial irradiation. There was no family history of endocrinological disorders or precocious puberty. At presentation, our patient was an alert child. Her height was 132 cm (>97th percentile) and 34.8 kg in weight (>97th percentile). Her vital signs were normal. She had normal ocular, thyroid and cardiorespiratory examinations. She had Tanner stage III breast development and pubic hair of Tanner stage II .
Her bone age was 11 years at a chronological age of 5 years and 7 months. USS abdomen revealed normal ovaries but the uterus was large for age (5.8 × 2.7 × 2.2 cm) Case report and adrenals were normal. Her haematological and biochemical parameters were within normal limits. Hormonal assay revealed the following: 8 am serum follicle stimulating hormone (FSH) and LH were 8.24 mIU/ml (follicular phase-2.8 -11.3) and 2.08 mIU/ml (follicular phase -1.1 -11.6) respectively while midnight FSH and LH were 3.85 mIU/ml (follicular phase -2.8 -11.3) and 3.77 mIU/ml (follicular phase -1.1 -11.6) respectively. Serum estradiol 59 pg/ml (39 -189), 3rd gen TSH -2.29 mIu/ml (6y -0.34-6.0), 8 am serum cortisol -13.8 μg/dl (2-6 years 1-26), serum prolactin -8.32 ng/ml (6-10 years -1.2-11.4) and serum Insulin like Growth Factor (IGF 1) -628 ng/ml (6yr -52-297) (11 yr -111 -551). Hormonal assay revealed elevated levels of serum FSH, LH, and serum estradiol confirming the clinical diagnosis of CPP. Interestingly her serum IGF-1 was elevated even when compared to her advanced bone age.
Magnetic resonance imaging (MRI) of the brain was reported to have an early anterior pituitary tumour without mass effect (Figure 2 & 3) . Considering the elevated serum IGF level and the MRI findings the patient underwent a standard 75mg oral glucose tolerance test (OGTT) ( Table 1 ). 
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As the 75g OGTT was inconclusive she also underwent a 9 point growth hormone (GH) assessment, which showed a normal pulsatile secretary pattern of GH (Table 2) . It has been reported that the size of the pituitary gland enlarges during puberty (10, 11, 12) . This was the reason for the MRI findings and the normal GH assay in our patient. After proper counseling of the parents it was decided to treat the patient with depot Goserelin acetate 3.6 mg monthly. After 9 months of follow up, the child's growth stabilized with regression of breast tissue and cessation of menstruation.
Discussion
MRI is not indicated in all patients presenting with CPP (3). For healthy girls aged 6-8 years with no signs or symptoms of CNS disease, the likelihood of finding a tumor or intracerebral pathology is only about 2%; therefore, this test may be unnecessary depending on the clinical situation. But among children younger than 6 years there is a greater chance of finding CNS pathology, therefore MRI is routinely indicated in these children (4) .
With the recent advances, MRI has become the investigation of choice for visualizing intracranial structures including the pituitary gland. Various studies depending on MRI findings of the pituitary in different age groups, have described the dynamic changes in the size, shape and signal intensity of the pituitary in these age groups, which reflects the changes in the complex hormonal environment of this gland (5, 6, 7) . These changes were more significant in females. The height of the anteriorpituitary gland increases between birth and 15 years, with two peaks, one during the first year of life and the second during puberty. Increased secretion of LH and FSH is the main cause of increased volume of the pituitary gland at puberty. It remains unchanged until the age of 40 years, after which it decreases (8) . This decrease occurs despite of an increase in gonadotrophin secretion at this age. It has also been found that pituitary volume followed the same morphological growth pattern that is reported for pituitary height. The maximum volume of the gland was achieved in the second decade of life for females and third decade for males (9) .
There are also published data which have compared MRI findings of the pituitary glands of children with central precocious puberty with age and sex matched control subjects. These studies were helpful in defining MRI-derived variables in the diagnosis of central precocious puberty, and to correlate them with the hormonal profile and other imaging and clinical findings. These variables were pituitary height, length, width, midsagittal cross-sectional area, calculated volume, and shape. The shape was assessed by a pituitary grading system which was defined by the concavity of the upper pituitary surface (grade 1 = marked concavity, grade 2 = mild concavity, grade 3 = flat, grade 4 = mild convexity, grade 5 = marked convexity). The results concluded that pituitary size and shape correlated with the hormonal profile and change in pituitary grade is the most helpful variable for the diagnosis of central precocious puberty in a prepubertal child (10, 11, 12) .
Conclusion
In conclusion, this report emphasizes the need for careful interpretation of the MRI imaging before arriving at a diagnosis in patients with CPP. The normal variation of enlargement in height and volume of the pituitary gland should always be considered in the differential diagnosis of the pituitary enlargement in these patients.
